| Financial Year |
September 30 2020 |
| Monetary Funds |
2,584,977,203.24 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
321,157,595.78 |
| Accounts Receivable |
180,219,673.77 |
| Advances to Suppliers |
6,265,502.39 |
| Other Receivables |
1,041,794.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
33,884,518.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,469,985.98 |
| Total Current Assets |
3,140,016,274.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
540,382,003.25 |
| Investment Properties |
-- |
| Fixed Assetes |
8,426,967,765.22 |
| Under-construction Projects |
611,638,877.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
997,462,803.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
190,356,039.84 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
10,766,807,489.54 |
| Total Assets |
13,906,823,764.06 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
81,887,773.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,708,128.32 |
| Taxes Payable |
54,450,425.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,636,618.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
305,026,031.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
32,760,218.42 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
72,756,622.92 |
| Total Liabilities |
377,782,654.30 |
| Paid-In Capital(Or Share Stock) |
6,472,983,003.00 |
| Capital Surplus |
1,537,045,501.44 |
| Surplus Reserve |
686,687,457.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,191,026,494.12 |
| Minority Stockholder's Interest |
563,062,603.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,965,978,506.73 |
| Owner's Equity（Stockholder's Equity） |
13,529,041,109.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,906,823,764.06 |
